UK's Indivior rises on beating first quarter revenue view
View all comments(0)
Shares of anti-opioid treatment maker Indivior INDV.L rise as much as 6.3% to 738.5p
Co reports Q1 total net revenue of $266 million, which was above consensus of $243 million, according to Jefferies analysts
Co also reiterated its FY2025 guidance
Adds it expects its key product, SUBLOCADE, to grow again in second-half of the year
Up to Wednesday's close, stock had fallen about 31% so far this year
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.